IRF1 and Miyoshi myopathy: Panobinostat reduced IRF1 protein levels in MM cells in the presence of IFN-γ at 24 hours (Figure 3C and 3D), whereas IRF1 mRNA levels remained at increased levels (Supplementary Figure 2A).